FCGR3A and B-cell chronic lymphocytic leukemia: Furthermore, the addition of a neutralizing anti-TGFβ antibody to monocytes pre-cultured with CLL-cm down-regulated CD16 expression (Figure 7B) and contemporarily inhibited osteoclast differentiation (Figure 7C).